Resources
Proteomics Databases
Metabolomics Databases

-
• Critical Review of Bottom-Up Proteomics
Review the strengths, limitations, and practical trade-offs of bottom-up proteomics in protein identification, quantitation, and PTM analysis.
-
• Comprehensive Overview of Bottom-Up Proteomics Using Mass Spectrometry
Overview of bottom-up proteomics using mass spectrometry, covering LC-MS/MS workflow, quantification modes, platform fit, applications, and reporting.
-
• Bottom-Up vs. Top-Down Proteomics: How to Choose the Right Strategy for Protein Characterization
Compare bottom-up and top-down proteomics for protein characterization by structural resolution, sample complexity, proteoform context, and decision criteria for biologics QC and comparability.
-
• Bottom-Up Proteomics: Workflow, LC-MS/MS Principles, and Applications in Protein Analysis
Learn bottom-up proteomics workflow, LC-MS/MS principles, and protein analysis applications for identification, quantitation, PTM mapping, and biologics characterization.
-
• Bottom-Up Proteomics: Principles, Workflow, and Analysis
Learn bottom-up proteomics principles, standard workflow steps, and analysis pipeline design for peptide identification, protein inference, and quantification.
-
• Basics of Protein and Antibody Glycosylation
Learn the basics of protein and antibody glycosylation, including N-linked and O-linked structures, analytical methods, and applications in biopharmaceutical characterization.
-
• Antibody Glycosylation in Inflammation, Disease and Vaccination
Explore antibody glycosylation in inflammation, disease, and vaccination, including IgG Fc glycan shifts, effector modulation, vaccine response maturation, and glycan profiling in immune research.
-
• Antibody Glycosylation in Autoimmune Diseases
Learn how antibody glycosylation influences autoimmune disease activity, effector function, and IgG effector profiles in rheumatoid arthritis, lupus, and related conditions.
-
Learn antibody glycosylation analysis methods, workflow, and applications in biotherapeutic characterization, including released N-glycan profiling, glycopeptide LC-MS/MS, comparability, and biosimilar support.
-
• N-Terminal Sequencing: Approaches for Confirming Mature Protein Starts and Processing Sites
Many proteins do not begin with the first residue encoded in the gene. Signal peptides are removed during secretion. Propeptides may be cleaved before the mature form becomes active. Recombinant expression systems can leave unintended N-terminal extensions or fail to remove leader sequences as expected. In each case, the biologically relevant question is not only what the gene encodes, but where the mature protein actually starts.
How to order?
